Skip to main content

MYLAN 2047 MYLAN 2047 Pill: gray & red, capsule/oblong, 14mm

The pill with imprint MYLAN 2047 MYLAN 2047 (Gray & Red, Capsule/Oblong, 14mm) has been identified as Tacrolimus 5 mg and is used for Organ Transplant, Rejection Prophylaxis, and Organ Transplant, Rejection Reversal. It belongs to the drug class calcineurin inhibitors and is not a controlled substance.

Images for MYLAN 2047 MYLAN 2047

Tacrolimus 5 mg MYLAN 2047 MYLAN 2047
Tacrolimus 5 mg MYLAN 2047 MYLAN 2047

Tacrolimus

Imprint
MYLAN 2047 MYLAN 2047
Strength
5 mg
Color
Gray & Red
Size
14.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Calcineurin inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
lactose anhydrous, ferrosoferric oxide, silicon dioxide, croscarmellose sodium, gelatin, hypromelloses, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, titanium dioxide, ferric oxide yellow, D&C Red No. 28, D&C Yellow No. 10, D&C Red No. 33, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-2047 Mylan Pharmaceuticals Inc.
51079-0028 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.